Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guerin Treatment in Non-muscle-invasive Bladder Cancer


Tonyali S., KARAASLAN M., Yılmaz M., CEYLAN C.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, vol.17, no.4, pp.120-123, 2018 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.4274/uob.1001
  • Journal Name: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.120-123
  • Istanbul University Affiliated: No

Abstract

Objective: To reveal the association of side effect profiles seen in patients receiving intravesical bacillus Calmette-Guerin (BCG) immunotherapy for non-muscle-invasive bladder cancer (NMIBC) treatment with patient age and possible changes over time due to the use of different BCG strains.